So, to answer the question directly: yes, retatrutide is injected into fat specifically, the subcutaneous fat layer
From a research standpoint, the main distinction is GLP-1-only pathway interest compared with a dual incretin pathway model
Retatrutide represents the next generation of weight loss medications, developed by Eli Lilly as a once-weekly injectable peptide that targets three distinct metabolic pathways simultaneously
If you were on Mounjaro 5 mg, starting Ozempic at 0.5 mg is common
It is practical protection against wasting money on a product that does not do what the research suggests the real molecule can do
Collagen production is already decreasing before any noticeable sagging appears and the skins support reduces gradually, thus making it ready for future loosening